Woodline Partners’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Woodline Partners’s Portfolio AONCW Stock Details AONCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,985	Closed	-$4.02M	–	830
2022 Q4	$4.02M	Sell	17,985 -28,585	-61%	-$2.34K	0.05%	350
2022 Q3	$3K	Sell	46,570 -53,430	-53%	-$5.23K	﹤0.01%	716
2022 Q2	$27K	Hold	100,000	–	–	﹤0.01%	658
2022 Q1	$40K	Hold	100,000	–	–	﹤0.01%	593
2021 Q4	$66K	Hold	100,000	–	–	﹤0.01%	613
2021 Q3	$69K	Hold	100,000	–	–	﹤0.01%	595
2021 Q2	$93K	Buy	+100,000	New	+$79.8K	﹤0.01%	508

Other funds holding AONCW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Woodline Partners's AONCW Position: Q1 2023 in Review

Woodline Partners sold out of American Oncology Network, Inc. Warrant (AONCW) in Q1 2023, closing a stake of 17,985 shares — an estimated $4.02M sold.

Woodline Partners first reported a position in AONCW in Q2 2021 and held it in 7 quarters. The position peaked at $4.02M in Q4 2022. 50 funds tracked by Wall St. Rank hold AONCW as of Q1 2023.

Woodline Partners reported no remaining American Oncology Network, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
Woodline Partners sold 17,985 American Oncology Network, Inc. Warrant shares in Q1 2023, an estimated $4.02M.
Woodline Partners first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 7 quarters.
Woodline Partners's American Oncology Network, Inc. Warrant position peaked at $4.02M in Q4 2022.
50 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.